A Dark Vector Cognition product

Item 5C. Plan 10b5-1 Plan Adoptions and Modification

2K characters. Original on sec.gov ·

Item 5C. Plan 10b5-1 Plan Adoptions and Modification

During the fiscal quarter covered by this Quarterly Report on Form 10-Q, Paul Ryan, President EMEA and an officer of the Company, adopted a "Rule 10b5-1 trading arrangement" (the "Ryan 10b5-1 Plan") as such each term is defined in Item 408(a) of Regulation S-K. The Ryan 10b5-1 Plan, adopted by Mr. Ryan on September 4, 2026, is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, and provides for the sale of up to 2,137 shares of Company Class A common stock and the exercise of options and same day sale of up to 36,662 shares of Company Class A common stock. The Ryan 10b5-1 Plan will remain in effect until the earlier of (1) September 3, 2027; (2) the first date on which all trades have been executed or all orders relating to such trades have expired; or (3) upon written notice by Mr. Ryan or the broker to terminate or modify the Ryan 10b5-1 Plan subject to and in compliance with the Company's insider trading policy and applicable securities laws.

During the fiscal quarter covered by this Quarterly Report on Form 10-Q, Anand Sanghi, President AMER and an officer of the Company, adopted a "Rule 10b5-1 trading arrangement" (the "Sanghi 10b5-1 Plan") as such each term is defined in Item 408(a) of Regulation S-K. The Sanghi 10b5-1 Plan, adopted by Mr. Sanghi on September 10, 2026, is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act, and provides for the exercise of options and same day sale of up to 250,508 shares of Company Class A common stock. The Sanghi 10b5-1 Plan will remain in effect until the earlier of (1) June 18, 2027; (2) the first date on which all trades have been executed or all orders relating to such trades have expired; or (3) upon written notice by Mr. Sanghi or the broker to terminate or modify the Sanghi 10b5-1 Plan subject to and in compliance with the Company's insider trading policy and applicable securities laws.

Previous: Item 5A. Other Information · Next: Item 6. EXHIBITS